학술논문

First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.
Document Type
Journal
Source
CANCER RESEARCH; APR 15 2013, 73 8, 1p. Supplement: 1
Subject
Language
English
ISSN
15387445